 |
|
The Therapeutic Effects of Bevacizumab in Patients with Polypoidal Choroidal Vasculopathy
Sun Young Lee, June-Gone Kim, Soo Geun Joe, Hyewon Chung, Young Hee Yoon
Korean J Ophthalmol. 2008;22(2):92-99. Published online 2008 Jun 20 DOI: https://doi.org/10.3341/kjo.2008.22.2.92
|
|
Citations to this article as recorded by
 Treatment Outcome of Wet Age-Related Macular Degeneration Management in Thailand: A Retrospective Real-World Study (TOWER Study)
Somanus Thoongsuwan, Prut Hanutsaha, Yodpong Chantarasorn, Paisan Ruamviboonsuk, Sritatath Vongkulsiri, Pavinee Kungwanpongpun
Ophthalmology and Therapy.2022; 11(2): 739. CrossRef Clinical explainable differential diagnosis of polypoidal choroidal vasculopathy and age-related macular degeneration using deep learning
Da Ma, Meenakshi Kumar, Vikas Khetan, Parveen Sen, Muna Bhende, Shuo Chen, Timothy T.L. Yu, Sieun Lee, Eduardo V. Navajas, Joanne A. Matsubara, Myeong Jin Ju, Marinko V. Sarunic, Rajiv Raman, Mirza Faisal Beg
Computers in Biology and Medicine.2022; 143: 105319. CrossRef Innovator Versus Biosimilar Ranibizumab in Polypoidal Choroidal Vasculopathy: Real-World Evidence
Manoj Soman, Indu Nair, Jay U. Sheth, Unnikrishnan Nair
Ophthalmology and Therapy.2022; 11(3): 1175. CrossRef Addition of photodynamic therapy to anti-vascular endothelial growth factor drugs compared to anti-vascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy
Franco Manzur Yarur, Victor Meza V, Rodolfo Garretón C, Aldo Muñoz Q
Medwave.2021; 21(08): e8460. CrossRef Effect of intravitreal injection of bevacizumab in treated and untreated eyes of Black African patients with polypoidal choroidal vasculopathy
N.N. Kabedi, D.L. Kayembe, J.C. Mwanza
Journal Français d'Ophtalmologie.2021; 44(10): 1505. CrossRef Therapeutic effects of ranibizumab in patients with polypoidal choroidal vasculopathy
Xiaoya Gu, Xiaobing Yu, Hong Dai
BMC Ophthalmology.2019;[Epub] CrossRef Polypoidal choroidal vasculopathy treatment options: A meta‐analysis
Tianwei Qian, Xinxin Li, Mengya Zhao, Xun Xu
European Journal of Clinical Investigation.2018;[Epub] CrossRef Polypoidal Choroidal Vasculopathy with Feeder Vessels: Characteristics, Fellow Eye Findings, and Long-term Treatment Outcomes
Hyun Ji Hwang, Jae Hui Kim, Young Suk Chang, Jong Woo Kim, Chul Gu Kim
Korean Journal of Ophthalmology.2017; 31(3): 230. CrossRef Treatment of Bilateral Retinal Angiomatous Proliferation with Anti-vascular Endothelial Growth Factor: 12-Month Outcome
Jae Min Kim, Jae Hui Kim, Young Suk Chang, Jong Woo Kim, Chul Gu Kim, Dong Won Lee
Korean Journal of Ophthalmology.2017; 31(3): 240. CrossRef Intravitreal Anti-vascular Endothelial Growth Factor for Treating Polypoidal Choroidal Vasculopathy with Grape-like Polyp Clusters
Young Suk Chang, Jae Hui Kim, Jong Woo Kim, Tae Gon Lee, Chul Gu Kim
Korean Journal of Ophthalmology.2016; 30(4): 272. CrossRef Optical Coherence Tomography-based Diagnosis of Polypoidal Choroidal Vasculopathy in Korean Patients
Young Suk Chang, Jae Hui Kim, Jong Woo Kim, Tae Gon Lee, Chul Gu Kim
Korean Journal of Ophthalmology.2016; 30(3): 198. CrossRef Intravitreal Anti-vascular Endothelial Growth Factor for Newly Diagnosed Symptomatic Polypoidal Choroidal Vasculopathy with Extrafoveal Polyps
Jae Hui Kim, Dong Won Lee, Sung Chan Choi, Jong Woo Kim, Tae Gon Lee, Chul Gu Kim, Han Joo Cho
Korean Journal of Ophthalmology.2015; 29(6): 404. CrossRef Clinical Outcomes of Eyes with Submacular Hemorrhage Secondary to Age-related Macular Degeneration Treated with Anti-vascular Endothelial Growth Factor
Kun Hae Kim, Jae Hui Kim, Young Suk Chang, Tae Gon Lee, Jong Woo Kim, Young Ju Lew
Korean Journal of Ophthalmology.2015; 29(5): 315. CrossRef Intravitreal Anti-vascular Endothelial Growth Factor for Typical Exudative Age-related Macular Degeneration in Eyes with Good Baseline Visual Acuity
Young Suk Chang, Jung Il Han, Su Jin Yoo, Young Ju Lew, Jae Hui Kim
Korean Journal of Ophthalmology.2014; 28(6): 466. CrossRef Polypoidal Choroidal Vasculopathy Exudation and Hemorrhage: Results of Monthly Ranibizumab Therapy at One Year
Gregg T. Kokame, Ling Yeung, Kyla Teramoto, James C. Lai, Raymond Wee
Ophthalmologica.2014; 231(2): 94. CrossRef The “Double-Layer Sign”
Jamie M. St. Martin, Julie Rodman, Joseph J. Pizzimenti, Eva Duchnowski
Optometry and Vision Science.2013; 90(12): e293. CrossRef Photodynamic therapy for polypoidal choroidal vasculopathy
Patrycja Nowak-Sliwinska, Hubert van den Bergh, Michel Sickenberg, Adrian H.C. Koh
Progress in Retinal and Eye Research.2013; 37: 182. CrossRef POLYPOIDAL CHOROIDAL VASCULOPATHY
Adrian H.C. Koh, Lee-Jen Chen, Shih-Jen Chen, Youxin Chen, Anantharam Giridhar, Tomohiro Iida, Hakyoung Kim, Timothy Yuk Yau Lai, Won Ki Lee, Xiaoxin Li, Tock Han Lim, Paisan Ruamviboonsuk, Tarun Sharma, Shibo Tang, Mitsuko Yuzawa
Retina.2013; 33(4): 686. CrossRef Argon Laser With and Without Anti-Vascular Endothelial Growth Factor Therapy for Extrafoveal Polypoidal Choroidal Vasculopathy
Chui Ming Gemmy Cheung, Ian Yeo, Xiang Li, Ranjana Mathur, Shu Yen Lee, Choi Mun Chan, Doric Wong, Tien Yin Wong
American Journal of Ophthalmology.2013; 155(2): 295. CrossRef ADJUSTED RETREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY AFTER COMBINATION THERAPY
Sohee Jeon, Won Ki Lee, Kyu Seop Kim
Retina.2013; 33(6): 1193. CrossRef INTRAVITREAL RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY IN NON-ASIAN PATIENTS
Dennis M. Marcus, Harinderjit Singh, McGregor N. Lott, Jasleen Singh, Madison D. Marcus
Retina.2013; 33(1): 35. CrossRef Treatment of Polypoidal Choroidal Vasculopathy With Photodynamic Therapy Combined With Intravitreal Injections of Ranibizumab
Kaoruko Tomita, Akitaka Tsujikawa, Kenji Yamashiro, Sotaro Ooto, Hiroshi Tamura, Atsushi Otani, Yoshihito Nakayama, Nagahisa Yoshimura
American Journal of Ophthalmology.2012; 153(1): 68. CrossRef Aportaciones en el tratamiento de formas atípicas de degeneración macular asociada a la enfermedad
E. Esteban González, E. Cervera Taulet
Archivos de la Sociedad Española de Oftalmología.2012; 87: 18. CrossRef Polypoidal Choroidal Vasculopathy—An Important Diagnosis to Make with Therapeutic Implications
Gregg T. Kokame
Retina.2012; 32(8): 1446. CrossRef One-Year Results of Intravitreal Ranibizumab with or without Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
Min-Hye Song, Hyun-Wook Ryu, Young-Jung Roh
Ophthalmologica.2011; 226(3): 119. CrossRef ONE-YEAR OUTCOMES OF INTRAVITREAL BEVACIZUMAB (AVASTIN) THERAPY FOR POLYPOIDAL CHOROIDAL VASCULOPATHY
Cheng-Kuo Cheng, Chi-Hsien Peng, Chun-Kai Chang, Chao-Chien Hu, Lee-Jen Chen
Retina.2011; 31(5): 846. CrossRef PHOTODYNAMIC THERAPY, RANIBIZUMAB, AND RANIBIZUMAB WITH PHOTODYNAMIC THERAPY FOR THE TREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY
Alexandros A Rouvas, Thanos D Papakostas, Amalia Ntouraki, Maria Douvali, Ioannis Vergados, Ioannis D Ladas
Retina.2011; 31(3): 464. CrossRef Correspondence
Jay Kumar Chhablani
Retina.2011; 31(3): 629. CrossRef NATURAL COURSE AND FUNDUSCOPIC FINDINGS OF POLYPOIDAL CHOROIDAL VASCULOPATHY IN A JAPANESE POPULATION OVER 1 YEAR OF FOLLOW-UP
Hiroaki Bessho, Shigeru Honda, Hisanori Imai, Akira Negi
Retina.2011; 31(8): 1598. CrossRef Photodynamic therapy for polypoidal choroidal vasculopathy
Jay Kumar Chhablani
Graefe's Archive for Clinical and Experimental Ophthalmology.2011; 249(5): 791. CrossRef A SYSTEMATIC REVIEW OF THE ADVERSE EVENTS OF INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS
Margriet I Van der Reis, Ellen C La Heij, Yvonne De Jong-Hesse, Peter J Ringens, Fred Hendrikse, Jan S A G Schouten
Retina.2011; 31(8): 1449. CrossRef Three-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy
Eriko Akaza, Mitsuko Yuzawa, Ryusaburo Mori
Japanese Journal of Ophthalmology.2011; 55(1): 39. CrossRef Development of polypoidal lesions in age-related macular degeneration
A Tsujikawa, Y Ojima, K Yamashiro, S Ooto, H Tamura, I Nakata, N Yoshimura
Eye.2011; 25(4): 481. CrossRef Reply
Sérgio Leal, Rufino Silva, João Figueira, M Luz Cachulo, Isabal Pires
Retina.2011; 31(1): 200. CrossRef Photodynamic Therapy Combined with Intravitreal Injection of Vascu lar Endothelial Growth Factor Antibody for Polypoidal Choroidal Vasculopathy
Sung Woon Moon, Moo Sang Kim, Eung Suk Kim, Seung-Young Yu, Hyung-Woo Kwak
Ophthalmologica.2011; 225(3): 169. CrossRef Correspondence
Jay Kumar Chhablani
Retina.2011; 31(1): 199. CrossRef Is Indocyanine Green Angiography Still Relevant?
Salomon Y Cohen, Lise Dubois, Gabriel Quentel, Alain Gaudric
Retina.2011; 31(2): 209. CrossRef Association of Lesion Size and Visual Prognosis to Polypoidal Choroidal Vasculopathy
Akitaka Tsujikawa, Yumiko Ojima, Kenji Yamashiro, Isao Nakata, Sotaro Ooto, Hiroshi Tamura, Hideo Nakanishi, Hisako Hayashi, Atsushi Otani, Nagahisa Yoshimura
American Journal of Ophthalmology.2011; 151(6): 961. CrossRef Combined Photodynamic Therapy and Intravitreal Bevacizumab Injection for Exudative Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
Mi Hyun Lee, Gi Hong Gu, Ji Eun Lee, Boo Sub Oum
Journal of the Korean Ophthalmological Society.2011; 52(7): 816. CrossRef EFFICACY OF COMBINED PHOTODYNAMIC THERAPY AND INTRAVITREAL BEVACIZUMAB INJECTION VERSUS PHOTODYNAMIC THERAPY ALONE IN POLYPOIDAL CHOROIDAL VASCULOPATHY
Sang Jin Kim, Hyeong Gon Yu
Retina.2011; 31(9): 1827. CrossRef Reduced-Fluence Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
Jay Chhablani
American Journal of Ophthalmology.2010; 150(3): 443. CrossRef Verteporfin PDT for non-standard indications—a review of current literature
Wai Man Chan, Tock-Han Lim, Alfredo Pece, Rufino Silva, Nagahisa Yoshimura
Graefe's Archive for Clinical and Experimental Ophthalmology.2010; 248(5): 613. CrossRef Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
Jay Kumar Chhablani
American Journal of Ophthalmology.2010; 150(5): 754. CrossRef Treatment of polypoidal choroidal vasculopathy by intravitreal injection of bevacizumab
Akitaka Tsujikawa, Sotaro Ooto, Kenji Yamashiro, Hiroshi Tamura, Atsushi Otani, Nagahisa Yoshimura
Japanese Journal of Ophthalmology.2010; 54(4): 310. CrossRef Efficacy of Intravitreal Bevacizumab Combined With Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
Fumi Gomi, Miki Sawa, Taku Wakabayashi, Yuzuru Sasamoto, Mihoko Suzuki, Motokazu Tsujikawa
American Journal of Ophthalmology.2010; 150(1): 48. CrossRef Functional changes following combined intravitreal bevacizumab and photodynamic therapy for polypoidal choroidal vasculopathy
Chengguo Zuo, Feng Wen, Jiaqing Li, Yan Liu, Shixian Long, Shizhou Huang, Meng Li
Graefe's Archive for Clinical and Experimental Ophthalmology.2010; 248(2): 191. CrossRef Polypoidal choroidal vasculopathy: an angiographic discussion
T H Lim, A Laude, C S H Tan
Eye.2010; 24(3): 483. CrossRef Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
Jay Kumar Chhablani
Journal of Ocular Pharmacology and Therapeutics.2010; 26(5): 529. CrossRef PHOTODYNAMIC THERAPY WITH VERTEPORFIN IN POLYPOIDAL CHOROIDAL VASCULOPATHY
Sérgio Leal, Rufino Silva, João Figueira, M Luz Cachulo, Isabel Pires, José Rui Faria de Abreu, José Guilherme Cunha-Vaz
Retina.2010; 30(8): 1197. CrossRef Polypoidal Choroidal Vasculopathy: A Review
Yutaka Imamura, Michael Engelbert, Tomohiro Iida, K. Bailey Freund, Lawrence A. Yannuzzi
Survey of Ophthalmology.2010; 55(6): 501. CrossRef Transitions of multifocal electroretinography following combined intravitreal bevacizumab and photodynamic therapy for polypoidal choroidal vasculopathy
Chengguo Zuo, Feng Wen, Jiaqing Li, Yan Liu, Meng Li
Documenta Ophthalmologica.2009; 119(1): 29. CrossRef Bevacizumab (Avastin) for the Treatment of Ocular Disease
Jonathan B. Gunther, Michael M. Altaweel
Survey of Ophthalmology.2009; 54(3): 372. CrossRef Indikationen für photodynamische Therapie mit Verteporfin im Zeitalter der intravitrealen Therapie – eine Übersicht
M. Stur
Spektrum der Augenheilkunde.2008; 22(6): 340. CrossRef
|